Abstract
Cognitive deficit is a typical complication induced by stroke injuries. Repetitive transcranial magnetic stimulation (rTMS) is a technique that can both attenuate neuropsychiatric disorders and influence miR levels. We attempted to assess effects of rTMS on post-stroke cognitive deficit (PSCD) by focusing on the activity of miR-409-3p/CTRP3/AMPK/Sirt1 axis. PSCD was induced in rats using middle cerebral artery occlusion (MCAO) method and handled with rTMS. MiRs responding to rTMS administration were determined using microarray method. Changes in cognitive function, brain histological feature, neuron apoptosis, and activity of miR-409-3p/CTR3/AMPK/Sirt1 axis were detected. The interaction between of miR-409-3p and rTMS was verified by inducing its level in MCAO rats. rTMS influenced levels of miRs in MCAO rats, with 104 miRs being upregulated and 249 s miR being downregulated, contributing to the function changes in multiple biological processes. Moreover, the technique improved brain function and structure in model rats. At the molecular level, rTMS inhibited miR-409-3p and activated CTRP3/AMPK/Sirt1 pathway. After the induction of miR-409-3p, effects of rTMS were counteracted, which were represented by the impaired cognitive function and neuron viability in model rats. Collectively, rTMS could protect against stroke-induced cognitive deficits, which depended on the inhibition of miR-409-3p level.
Similar content being viewed by others
Availability of Data and Materials
The data will be provided when required.
References
Ai J, Sun LH, Che H, Zhang R, Zhang TZ, Wu WC, Su XL, Chen X et al (2013) MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. J Neurosci 33:3989–4001
Almalki O, Alshehri MA, El-Sodany AM, El-Fiky AA (2018) The awareness of healthcare staff towards post-stroke cognitive impairment: a cross sectional study. J Phys Ther Sci 30:883–887
Barker AT (1994) Electricity, magnetism and the body: some uses and abuses. J R Soc Health 114:91–97
Barker AT, Jalinous R, Freeston IL (1985) Non-invasive magnetic stimulation of human motor cortex. Lancet 1:1106–1107
Blackman CF, Benane SG, Kinney LS, Joines WT, House DE (1982) Effects of ELF fields on calcium-ion efflux from brain tissue in vitro. Radiat Res 92:510–520
Boggio PS, Valasek CA, Campanhã C, Giglio AC, Baptista NI, Lapenta OM, Fregni F (2011) Non-invasive brain stimulation to assess and modulate neuroplasticity in Alzheimer’s disease. Neuropsychol Rehabil 21:703–716
Cao P, Wang L, Cheng Q, Sun X, Kang Q, Dai L, Zhou X, Song Z (2019) Changes in serum miRNA-let-7 level in children with attention deficit hyperactivity disorder treated by repetitive transcranial magnetic stimulation or atomoxetine: an exploratory trial. Psychiatry Res 274:189–194
Chen L, Qin L, Liu X, Meng X (2019a) CTRP3 alleviates Ox-LDL-induced inflammatory response and endothelial dysfunction in mouse aortic endothelial cells by activating the PI3K/Akt/eNOS pathway. Inflammation 42:1350–1359
Chen W, Sinha B, Li Y, Benowitz L, Chen Q, Zhang Z, Patel NJ, Aziz-Sultan AM et al (2019b) Monogenic, polygenic, and microRNA markers for ischemic stroke. Mol Neurobiol 56:1330–1343
Danielyan AA, Mirakyan MM, Grigoryan GY, Ayrapetyan SN (1999) The static magnetic field effects on ouabain H3 binding by cancer tissue. Physiol Chem Phys Med NMR 31:139–144
Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Tonali PA (2003) Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease: evidence of impaired glutamatergic neurotransmission?. Ann Neurol 53:824; author reply 824–825
Guo F, Han X, Zhang J, Zhao X, Lou J, Chen H, Huang X (2014) Repetitive transcranial magnetic stimulation promotes neural stem cell proliferation via the regulation of MiR-25 in a rat model of focal cerebral ischemia. PLoS One 9:e109267
Herrero Babiloni A, Bellemare A, Beetz G, Vinet SA, Martel MO, Lavigne GJ, De Beaumont L (2021) The effects of non-invasive brain stimulation on sleep disturbances among different neurological and neuropsychiatric conditions: A systematic review. Sleep Med Rev 55:101381
Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, Filipović SR, Grefkes C et al (2020) Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018). Clin Neurophysiol 131:474–528
Li H, Shang J, Zhang C, Lu R, Chen J, Zhou X (2020) Repetitive transcranial magnetic stimulation alleviates neurological deficits after cerebral ischemia through interaction between RACK1 and BDNF exon IV by the phosphorylation-dependent factor MeCP2. Neurotherapeutics 17:651–663
Liu D, Zhang C, Li X, Zhang H, Pang Q, Wan A (2018) MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma. Excli j 17:102–112
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408
Manenti R, Tettamanti M, Cotelli M, Miniussi C, Cappa SF (2010) The neural bases of word encoding and retrieval: a fMRI-guided transcranial magnetic stimulation study. Brain Topogr 22:318–332
Prabhakar P, Chandra SR, Christopher R (2017) Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease. Age Ageing 46:861–864
Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G et al (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379:2352–2363
Sharma H, Vishnu VY, Kumar N, Sreenivas V, Rajeswari MR, Bhatia R, Sharma R, Srivastava MVP (2020) Efficacy of low-frequency repetitive transcranial magnetic stimulation in ischemic stroke: a double-blind randomized controlled trial. Arch Rehabil Res Clin Transl 2:100039
Song XD, Li SX, Zhu M (2020) Plasma miR-409–3p promotes acute cerebral infarction via suppressing CTRP3. Kaohsiung J Med Sci
Sun HS, Jackson MF, Martin LJ, Jansen K, Teves L, Cui H, Kiyonaka S, Mori Y et al (2009) Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci 12:1300–1307
Sun HS, Xu B, Chen W, Xiao A, Turlova E, Alibraham A, Barszczyk A, Bae CY et al (2015) Neuronal K(ATP) channels mediate hypoxic preconditioning and reduce subsequent neonatal hypoxic-ischemic brain injury. Exp Neurol 263:161–171
Swartz RH, Bayley M, Lanctôt KL, Murray BJ, Cayley ML, Lien K, Sicard MN, Thorpe KE et al (2016) Post-stroke depression, obstructive sleep apnea, and cognitive impairment: rationale for, and barriers to, routine screening. Int J Stroke 11:509–518
Wang F, Zhao L, Shan Y, Li R, Qin G (2019) CTRP3 protects against high glucose-induced cell injury in human umbilical vein endothelial cells. Anal Cell Pathol (amst) 2019:7405602
Xie H, Zhao Y, Zhou Y, Liu L, Liu Y, Wang D, Zhang S, Yang M (2017) MiR-9 regulates the expression of BACE1 in dementia induced by chronic brain hypoperfusion in rats. Cell Physiol Biochem 42:1213–1226
Yang LH, Xu YC, Zhang W (2020) Neuroprotective effect of CTRP3 overexpression against sevoflurane anesthesia-induced cognitive dysfunction in aged rats through activating AMPK/SIRT1 and PI3K/AKT signaling pathways. Eur Rev Med Pharmacol Sci 24:5091–5100
Yu G, Wu F, Wang ES (2015) BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke. Int J Clin Exp Pathol 8:1213–1225
Yu P, Venkat P, Chopp M, Zacharek A, Shen Y, Ning R, Liang L, Li W et al (2019) Role of microRNA-126 in vascular cognitive impairment in mice. J Cereb Blood Flow Metab 39:2497–2511
Zhang J, Sun P, Zhou C, Zhang X, Ma F, Xu Y, Hamblin MH, Yin KJ (2020) Regulatory microRNAs and vascular cognitive impairment and dementia. CNS Neurosci Ther 26:1207–1218
Zhu C, Li G, Lv Z, Li J, Wang X, Kang J, Zhan C (2020) Association of plasma trimethylamine-N-oxide levels with post-stroke cognitive impairment: a 1-year longitudinal study. Neurol Sci 41:57–63
Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W (1996) The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 109:127–135
Author information
Authors and Affiliations
Contributions
TYW designed the study, performed lab experiments, and wrote the draft. TYW and CRT analyzed the data. JT designed the experiments and wrote the draft, revised the draft, and approved the submission.
Corresponding author
Ethics declarations
Ethics Approval
All the animal experiments were performed in accordance with the Institutional Animal Ethics Committee and Animal Care Guidelines of Zhuji People’s Hospital of Zhejiang Province, and followed the ARRIVE guidelines for animal research.
Consent for Publication
All the authors have approved the manuscript and have provided consent for its submission to your esteemed journal.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wu, T., Tang, C., Fan, J. et al. Administration of rTMS Alleviates Stroke-Induced Cognitive Deficits by Modulating miR-409-3p/CTRP3/AMPK/Sirt1 Axis. J Mol Neurosci 72, 507–515 (2022). https://doi.org/10.1007/s12031-021-01924-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-021-01924-5